Viewing Study NCT04648007



Ignite Creation Date: 2024-05-06 @ 3:28 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04648007
Status: UNKNOWN
Last Update Posted: 2020-12-01
First Post: 2020-11-23

Brief Title: Validation of Kaihani Score for Gambling Addiction
Sponsor: Therapeutic Solutions International
Organization: Therapeutic Solutions International

Study Overview

Official Title: Diagnostic Ability of Plasma Based Neuromodulatory Cytokine Production Kaihani Score in Gambling Addiction
Status: UNKNOWN
Status Verified Date: 2020-11
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The Kaihani Score is a blood based means of assessing molecules believed to be associated with gambling addiction

The current clinical trial will assess the Kaihani Score in 3 groups

Group 1 10 patients with no personal or family problems with gambling as assessed by the PG-YBOCS obsessions-compulsions scale Yale-Brown Y-BOCS adapted for pathological gambling PG-YBOCS

Group 2 10 patients with moderate gambling addiction as assessed by the PG-YBOCS obsessions-compulsions scale Yale-Brown Y-BOCS adapted for pathological gambling PG-YBOCS

Group 3 10 patients with severe gambling addiction as assessed by the PG-YBOCS obsessions-compulsions scale Yale-Brown Y-BOCS adapted for pathological gambling PG-YBOCS

The goal of the study is to confirm preliminary efficacy of the Kaihani Score as a blood based means of assessing gambling propensity
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None